Description of Business and Summary of Significant Accounting Policies (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2026 | ||||||||||||||||||||||||||||||||||||||||||||||
| Description of Business and Summary of Significant Accounting Policies [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Cash, Cash Equivalents and Restricted Cash |
The following is a summary of cash, cash equivalents and restricted cash at March 31, 2026 and December 31, 2025:
|
|||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Diluted Net Loss Per Share | For the three months ended March
31, 2026 and 2025, the Company’s potentially dilutive shares, which include outstanding common stock options, restricted stock units,
vested unissued shares of common stock and warrants, have not been included in the computation of diluted net loss per share as the result
would have been anti-dilutive.
|
|||||||||||||||||||||||||||||||||||||||||||||